Insights

Innovative Research Focus Eikon Therapeutics is at the forefront of biopharmaceutical innovation, leveraging advanced imaging techniques and machine learning to identify and develop novel therapies for cancer and neurological diseases. This focus creates opportunities to collaborate on cutting-edge drug discovery and personalized medicine solutions.

Strong Funding and Growth With recent Series D funding of over 350 million dollars, Eikon is fueling its clinical development pipeline and preparing for an IPO. This financial backing indicates a promising growth trajectory and potential for partnerships in clinical trial infrastructure and biotech investments.

Strategic Oncology Initiatives Eikon is actively developing systemic treatments like EIK1001 targeting non-small cell lung cancer, opening sales opportunities in pharmaceutical collaborations, clinical research services, and biotech partnerships to support their expanding oncology portfolio.

Leadership Expansion The company continues to strengthen its leadership with recent executive hires, including a new COO. This indicates an organizational focus on scaling operations and streamlining business development efforts, providing avenues for strategic collaboration and enterprise solutions.

Market Engagement Eikon regularly participates in high-profile industry events like the J.P. Morgan Healthcare Conference, showcasing their commitment to visibility and networking within the biotech community. This presents opportunities to establish strategic alliances, technology partnerships, and investment dialogues.

Eikon Therapeutics Tech Stack

Eikon Therapeutics uses 8 technology products and services including GDPR, Cloudflare, Selenium, and more. Explore Eikon Therapeutics's tech stack below.

  • GDPR
    Certificates
  • Cloudflare
    Content Management System
  • Selenium
    Frameworks And Libraries
  • Vue.js
    Javascript Frameworks
  • Lenis
    Javascript Libraries
  • Planisware
    Project Management
  • Yoast SEO
    Search Engines
  • Autodesk
    Visualisation Software

Media & News

Eikon Therapeutics's Email Address Formats

Eikon Therapeutics uses at least 1 format(s):
Eikon Therapeutics Email FormatsExamplePercentage
LastF@eikontx.comDoeJ@eikontx.com
62%
First@eikontx.comJohn@eikontx.com
17%
First.Last@eikontx.comJohn.Doe@eikontx.com
12%
LF@eikontx.comDJ@eikontx.com
9%

Frequently Asked Questions

Where is Eikon Therapeutics's headquarters located?

Minus sign iconPlus sign icon
Eikon Therapeutics's main headquarters is located at 230 Harriet Tubman Way Millbrae, California 94030 United States. The company has employees across 4 continents, including North AmericaEuropeSouth America.

What is Eikon Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Eikon Therapeutics's official website is eikontx.com and has social profiles on LinkedInCrunchbase.

What is Eikon Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
Eikon Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Eikon Therapeutics have currently?

Minus sign iconPlus sign icon
As of February 2026, Eikon Therapeutics has approximately 391 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Business Officer & General Counsel: B. T.Chief Operating Officer: M. K.Chief People Officer: B. H.. Explore Eikon Therapeutics's employee directory with LeadIQ.

What industry does Eikon Therapeutics belong to?

Minus sign iconPlus sign icon
Eikon Therapeutics operates in the Biotechnology Research industry.

What technology does Eikon Therapeutics use?

Minus sign iconPlus sign icon
Eikon Therapeutics's tech stack includes GDPRCloudflareSeleniumVue.jsLenisPlaniswareYoast SEOAutodesk.

What is Eikon Therapeutics's email format?

Minus sign iconPlus sign icon
Eikon Therapeutics's email format typically follows the pattern of LastF@eikontx.com. Find more Eikon Therapeutics email formats with LeadIQ.

How much funding has Eikon Therapeutics raised to date?

Minus sign iconPlus sign icon
As of February 2026, Eikon Therapeutics has raised $351M in funding. The last funding round occurred on Feb 26, 2025 for $351M.

When was Eikon Therapeutics founded?

Minus sign iconPlus sign icon
Eikon Therapeutics was founded in 2019.

Eikon Therapeutics

Biotechnology ResearchCalifornia, United States201-500 Employees

Eikon Therapeutics is a late-stage clinical biopharmaceutical company advancing a pipeline of potential therapies for patients with unmet medical needs. We are passionate about novel therapeutics and share the belief that a better understanding of fundamental human disease biology can lead to better medicines. We are driven to go beyond incremental improvements. Instead, our goal is to introduce new therapies into clinical practice that will improve and extend life. Our clinical programs in oncology leverage immune response modulation and synthetic lethality to improve cancer therapy, while our discovery efforts are focused on identifying novel targets through application of single-molecule imaging to the study of cancer and neurological diseases. By applying machine learning algorithms to the very large imaging data sets that emerge from our imaging platforms, we can advance our programs towards our ultimate goal of discovering and developing better medicines. 

Eikon is seeking intellectually curious, passionate, and creative team members that are eager to apply their talents to empower interdisciplinary scientific exploration and ultimately create and develop novel medicines. To learn more about open positions, please visit: https://www.eikontx.com/join-us/#open-positions

Section iconCompany Overview

Headquarters
230 Harriet Tubman Way Millbrae, California 94030 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
201-500

Section iconFunding & Financials

  • $351M

    Eikon Therapeutics has raised a total of $351M of funding over 5 rounds. Their latest funding round was raised on Feb 26, 2025 in the amount of $351M.

  • $100M$250M

    Eikon Therapeutics's revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $351M

    Eikon Therapeutics has raised a total of $351M of funding over 5 rounds. Their latest funding round was raised on Feb 26, 2025 in the amount of $351M.

  • $100M$250M

    Eikon Therapeutics's revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.